Home › Endometrial Cancer › Washington › Vancouver
Endometrial Cancer clinical trials in Vancouver, WA
3 studies for Endometrial Cancer are looking for participants at sites in and around Vancouver (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RecruitingPhase 3
- Legacy Salmon Creek Hospital, Vancouver
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
RecruitingPhase 3
- USOR - NW Cancer Specs P.C., Vancouver
Symbiotic-GYN-18: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Advanced or Recurrent MMR-proficient Endometrial Cancer
RecruitingPhase 3
- Northwest Cancer Specialists, P.C., Vancouver
Endometrial Cancer trials in other cities
- Houston, TX69 studies
- New York City, NY54 studies
- Boston, MA51 studies
- Arlington, VA41 studies
- Nashville, TN38 studies
- Los Angeles, CA35 studies
- St. Louis, MO29 studies
- Philadelphia, PA29 studies
- Oklahoma City, OK28 studies
- San Antonio, TX27 studies
- Queens, NY26 studies
- Dallas, TX25 studies
Other studies in Vancouver
- Non-Small Cell Lung Cancer9 studies
- Lung Cancer7 studies
- Colorectal Cancer6 studies
- Breast Cancer5 studies
- Pancreatic Cancer4 studies
- Metastatic Cancer4 studies
- Prostate Cancer4 studies
- Cancer (all types)3 studies
- Head and Neck Squamous Cell Carcinoma3 studies
- Crohn's Disease3 studies
- Ulcerative Colitis3 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.